Status:
COMPLETED
Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
University Ghent
GlaxoSmithKline
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This study would like to test the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in Chronic Obstructive Pulmonary Disease (COPD)...
Detailed Description
Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only involves prescription of recommended medicines by the physician, but also implies correct use of the prescri...
Eligibility Criteria
Inclusion
- daily use of Chronic Obstructive Pulmonary Disease (COPD)-medication: (Global initiative for chronic Obstructive Lung Disease: GOLD stadia I-IV)
- 50 years of age or older
- smoking history of at least 10 pack-years
Exclusion
- having asthma
- analphabetism
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
734 Patients enrolled
Trial Details
Trial ID
NCT01260389
Start Date
December 1 2010
End Date
July 1 2011
Last Update
July 13 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University
Ghent, Belgium
2
Centre Hospitalier Universitaire du Sart Tilman
Liège, Belgium